Collegium Pharmaceutical, Inc. · NASDAQ:COLL
Freund John Gordon sold 4,127 Collegium Pharmaceutical, Inc. shares (Form 4)
Traded May 14 to May 15, 2026 · Filed May 18, 2026
From May 14 to May 15, 2026, Freund John Gordon (Director) sold 4,127 Collegium Pharmaceutical, Inc. shares at US$34.54 for US$143K, leaving 83,972 shares. Filed May 18, 2026 (Form 4).
- Sold
- 4,127 shares
- Price
- US$34.54
- Value
- US$143K
- Holding after
- 83,972 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Award | 8,741 | 79,399 | Direct | |
| May 15, 2026 | Common Stock | Option exercise | 8,700 | US$16.49 | 88,099 | Direct |
| May 15, 2026 | Common Stock | Sale | 4,127 | US$34.54 | 83,972 | Direct |
Source
Related
- Collegium Pharmaceutical, Inc.
- Freund John Gordon
- Collegium Pharmaceutical, Inc. shareholders
- Form 4 · Freund John Gordon · May 20, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Schedule 13G · Fuller & Thaler Asset Management, Inc. · Aug 14, 2026
- Schedule 13G · Principal Global Investors · Aug 5, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026